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INTRODUCTION
Pancreatic b cell Ca 2+ influx triggers insulin secretion, and endoplasmic reticulum (ER) Ca 2+ (Ca 2+ ER ) handling plays a key role in this process (1) . Ca 2+ ER serves many essential functions in b cells, such as controlling protein processing and metabolism, and defects in Ca 2+ ER homeostasis can trigger the unfolded protein response (2) . The importance of precise b cell Ca 2+ ER handling is evident in type 1 and type 2 diabetes mellitus (T2DM), during which Ca 2+ ER homeostasis is disrupted, leading to b cell dysfunction and eventual destruction (1) (2) (3) (4) (5) (6) (7) (8) . Impaired Ca 2+ ER handling also causes defects in glucose-stimulated insulin secretion (GSIS), contributing to hyperglycemia (3, 9) . Therefore, treatments that reduce ER stress in the context of b cell dysfunction improve glucose tolerance (10) (11) (12) . However, although it is known that b cell Ca 2+ ER concentrations are perturbed in diabetes (2, (4) (5) (6) (7) , the molecular determinants that set b cell Ca 2+ ER are poorly understood. Maintenance of Ca 2+ ER homeostasis requires that Ca 2+ movement across the ER membrane is balanced with a simultaneous K + flux in the opposite direction (13) (14) (15) . Without this K + countercurrent, Ca 2+ release from the ER would rapidly generate a negative charge on the inside of the ER membrane, inhibiting further Ca 2+ ER release. To date, only a few ER K + channels have been identified, including trimeric intracellular cation-A (TRIC-A) channels, which regulate Ca 2+ ER stores in myocytes (16, 17) ; TRIC-B channels, which control Ca 2+ ER homeostasis in alveolar epithelial cells and osteoblasts (18, 19) ; and small-conductance Ca 2+ -activated K + (K Ca ) channels (SK channels), which modulate Ca 2+ ER uptake in neurons and cardiomyocytes (20) . Genetic ablation or pharmacological inhibition of these channels impairs Ca 2+ ER handling. For example, knockout (KO) of TRIC-A or TRIC-B channels results in increased Ca 2+ ER stores, presumably due to the loss of a K + countercurrent that regulates the ability of Ca 2+ to exit the ER (15, 16, 18) . Despite the importance of K + countercurrents in maintaining Ca 2+ ER homeostasis, nothing is known about the mediators or functions of b cell ER K + countercurrents.
ER localization has been reported for several two-pore domain K + (K2P) channels, including TASK-1 (21), TASK-3 (22) , TASK-5 (23), TWIK-2 (24, 25) , and THIK-2 (24) . Although the subcellular localization of TALK-1 channels has not been reported, a protein interactome study has determined that a majority (>60%) of the proteins interacting with TALK-1 are ER-resident proteins (26) . Similarly, a human pancreatic islet cDNA library generated and screened in a membrane yeast twohybrid assay to identify islet TALK-1-interacting proteins detected multiple ER-resident proteins that interact with TALK-1 (27) . In accordance with these observations, TALK-1 shows substantial intracellular staining in human and mouse pancreatic b cells (28) . Although these findings suggest that TALK-1 channels may serve an intracellular role, investigations of intracellular K2P channels have focused primarily on elucidating the factors that enable their functional expression on the plasma membrane, and an ER function for K2P channels has not been identified. In b cells, TALK-1 contributes to plasma membrane potential (V m ) hyperpolarization, thereby regulating cytosolic Ca 2+ (Ca 2+ c ) influx and insulin secretion (28) . TALK-1 is distributed in pancreatic islets and gastric somatostatin cells (29, 30) and is the most abundant islet K + channel at the transcriptional level (31) (32) (33) . A primary physiological function of b cell TALK-1 channels is to limit glucose-induced islet electrical and Ca 2+ c oscillations, controlling second-phase pulsatile insulin secretion (28) . Furthermore, a nonsynonymous polymorphism in TALK-1 (rs1535500) associated with T2DM (34) (35) (36) causes a gain of function in TALK-1 activity (28) , which may impair Ca 2+ c oscillations and pulsatile insulin secretion. However, the molecular mechanisms underlying TALK-1 regulation of islet Ca 2+ c oscillations remain unclear.
Here, we tested the hypothesis that TALK-1 channels were functional in the ER and mediated ER ER homeostasis. Moreover, islets from mice lacking TALK-1 channels showed reduced signs of ER stress induced by chronic exposure to a high-fat diet (HFD), suggesting that defects in TALK-1 channel activity can perturb ER health and contribute to islet dysfunction in T2DM. Overall, these findings identify an intracellular function of K2P channels and reveal TALK-1 channels as a possible therapeutic target to modulate Ca 2+ ER homeostasis to reduce b cell ER stress in diabetes.
RESULTS

TALK-1 activity promotes Ca
2+
ER leak TALK-1's prominent intracellular staining pattern (28) and physical association with several ER-resident proteins (26) suggested that TALK-1 could be localized to the ER. To determine the subcellular localization of TALK-1, we performed immunofluorescence staining of mouse pancreas sections and detected colocalization of TALK-1 with the ER marker calreticulin (Fig. 1A) . In addition, coexpression of a TALK-1/ mCherry fusion protein and an ER-targeted indicator (37) (Fig. 1B) (38) . Under both low and high glucose conditions, TALK-1 KO b cells had significantly higher Ca 2+ ER concentrations (Fig. 1, B and C). Inhibition of sarco-endoplasmic Ca 2+ adenosine triphosphatases (SERCAs) with cyclopiazonic acid (CPA) produced a greater decrease in Ca 2+ ER in KO b cells compared with controls (Fig. 1D) . Statistical significance was determined by Student's t test; *P < 0.05, **P < 0.01, ***P < 0.005. (Fig. 1, E and G) .
S C I E N C E S I G N A L I N G | R E S E A R C H A R T I C L E
Because TALK-1 is also detected in human b cells (28), we next examined whether TALK-1 was present in the ER of human b cells. Immunofluorescent staining of human pancreas sections revealed colocalization of TALK-1 with the ER marker calreticulin ( Fig. 2A) . To assess TALK-1-mediated regulation of human b cell Ca 2+ ER , we measured CPA-induced Ca 2+ ER release in b cells expressing a dominantnegative TALK-1 (TALK-1 DN) construct (Fig. 2B) . The TALK-1 DN contains a pore mutation, which inhibits K + conductance when it interacts with endogenous TALK-1 (28) . The TALK-1 DN construct also contains a P2A element between the sequences encoding TALK-1 and an mCherry reporter, allowing us to detect cells expressing the TALK-1 DN by mCherry fluorescence; b cells were identified by poststaining for insulin (28 (Fig. 4A and fig. S4 , A and B) (43) . Similar to transfected cells, TALK-1 induction reduced Ca 2+ ER stores (Fig. 4A) . We also found that expression of TASK-1 (Fig. 4A) (14, 16, 48, 49) . To directly assess whether TALK-1 functions as an ER K + channel, we used nuclear patch clamp electrophysiology (50) to measure channel activity on the outer nuclear membrane, which is continuous with the ER (Fig. 5, A and B) . In nuclei from cells expressing TREK-2, which does not affect Ca 2+ ER , we did not detect TREK-2 channel activity (Fig. 5C ). However, nuclei from cells expressing TALK-1 (Fig. 5D ) or TASK-1 ( + flux through TALK-1 supports the movement of Ca 2+ across the ER membrane. We also examined whether TALK-1 functions as an ER K + channel in primary cells by performing nuclear patch clamp recordings on nuclei isolated from wild-type and TALK-1 KO islets. We detected single-channel openings ( Fig. 5F ) with a current amplitude comparable to cloned TALK-1 in 55.6 ± 6.3% of wild-type islet cell nuclei (Fig. 5G) . However, only 31.2 ± 2.7% of nuclei from TALK-1 KO islets displayed K2P-like channel openings (Fig. 5H ). Together, our findings suggest that TALK-1 and TASK-1 form functional channels on the ER membrane, allowing for a K + countercurrent that supports Ca (Fig. 6A) (51) . Under these conditions, the role of plasma membrane TALK-1 channels is effectively dissociated from its intracellular functions: Diazoxide circumvents the depolarizing effects of glucose by activating K ATP channels, and K + depolarization activates voltage-dependent Ca 2+ channels (VDCCs) independently of K + channel activity (52 ER to prechannel expression concentrations (C); AUC quantification (D) (n = 3 independent experiments). (E) Mouse a cells were treated with ML365 in the presence of 11 mM glucose and 125 mM diazoxide (representative of n = 3 independent experiments). The response to CPA is quantified in (F) (n = 3 independent experiments). Statistical significance was determined by Student's t test; *P < 0.05, **P < 0.01, ***P < 0.005.
Ca 2+
ER release (53) (54) (55) . In KO islets, V m repolarization is reduced by about 50% at the termination of each electrical oscillation (28), suggesting that K slow may be impaired in KO islets. We tested this notion by measuring K slow in wild-type and KO b cells. K slow amplitude (Fig. 7A , inset) was reduced in KO b cells by 48 ± 17% relative to wild-type b cells (Fig. 7, B and C) . TALK-1 is not activated by Ca 2+ c in oocytes (59), and we also found that TALK-1 activity in HEK293 (Fig. 7D) or b cells (Fig.  7E ) was insensitive to Ca 2+ c , making it unlikely that TALK-1 is a constituent channel of K slow . These findings suggest that TALK-1 may modulate b cell K slow indirectly through control of Ca 2+ ER homeostasis. To assess whether modulation of K2P channels activity affects depolarization-induced Ca 2+ ER uptake and release, we inhibited TASK-1 in a cells with ML365. We found that TASK-1 channel inhibition reduced Ca 2+ ER release induced by V m depolarization (Fig. 7G) (51) , suggesting that TASK-1 facilitates a cell Ca 2+ ER release.
TALK-1 channel activity exacerbates islet ER stress
Reduced b cell Ca 2+ ER content is associated with ER stress and islet dysfunction in diabetes (4, (60) (61) (62) (63) . Our results indicated that TALK-1 channels were a determinant of b cell Ca 2+ ER concentrations and suggested that TALK-1 channel activity could exacerbate Ca 2+ ER depletion, which leads to ER stress. Therefore, we determined whether the absence of functional TALK-1 channels affected islet responses to the metabolic stress of a HFD. After 1 week of HFD feeding, the expression of genes involved in ER stress signaling did not differ between wild-type and TALK-1 KO islets (Fig. 8A) . SERCA abundance is reported to change as a function of Ca 2+ ER content (64, 65) ; however, we did not detect differences in the expression of mRNAs encoding SERCA2b and SERCA3 in wild-type and TALK-1 KO islets. However, after prolonged (20 weeks) exposure to an HFD, TALK-1 KO islets exhibited decreased expression of multiple ER stress genes, as well as significantly decreased expression of mRNA encoding SERCA2b and SERCA3 (Fig. 8B) . The decreased SERCA expression may represent a compensatory mechanism to reduce Ca 2+ ER overloading and maintain b cell Ca 2+ ER concentrations in an optimal range. We also assessed whether the T2DM-linked gain-of-function polymorphism (rs1535500) encoding TALK-1 A277E (28) interfered with ER function. Activating transcription factor 6 (ATF6) transcriptional activation occurs in response to Ca 2+ ER depletion and protein misfolding (65, 66), which we measured in INS-1 cells [with a luciferase reporter containing five tandem repeats of ATF6-binding sites (67, 68) ] after application of tunicamycin, which inhibits protein glycosylation and causes protein misfolding and ER stress. INS-1 cells expressing wildtype TALK-1 or TALK-1 A277E were significantly more susceptible to tunicamycin-induced ATF6 activation than cells expressing the nonconducting TALK-1 DN. Furthermore, TALK-1 A277E activated ATF6 to a significantly greater extent than wild-type TALK-1 (Fig. 8C) . However, coexpression of TALK-1 A277E with the TALK-1 DN reduced ATF6 activation to amounts comparable to that induced by expression of TALK-1 DN alone (Fig. 8C) . INS-1 cells expressing TALK-1 A277E showed reduced Ca 2+ ER concentrations compared to cells expressing wild-type TALK-1 (Fig. 8D) . Statistical significance was determined by Student' s t test; *P < 0.05, **P < 0.01, ***P < 0.005. ER release serves an important role in regulating second-phase Ca 2+ c influx and insulin secretion, which are increased when SERCAs are inhibited pharmacologically and is also observed in islets lacking SERCA3 (38, 73, 74) . Similarly, we find that both second-phase Ca 2+ c and insulin secretion are increased in the absence of functional TALK-1 channels (28). These observations suggest that TALK-1 modulation of the Ca 2+ ER handling, which controls second-phase insulin secretion, is a key physiological function of b cell TALK-1 channels.
S C I E N C E S I G N A L I N G | R E S E A R C H A R T I C L E
As mentioned above, TALK-1 KO islets exhibit increased insulin secretion, a higher frequency of Ca 2+ c oscillations, and increased plateau fraction (the fraction of time spent in electrically excitable periods) (28) . The present study helps resolve the molecular mechanisms underlying these phenotypes. A rationale for the increased plateau fraction and oscillation frequency in TALK-1 KO islets is that ER TALK-1 channels sustain Ca ER , such as mitochondrial ATP production, which energizes the b cell SERCA pump (78) .
Our observations suggested that TALK-1 activity controls Ca release in ML365-treated a cells (n = 11 cells per condition). Statistical significance was determined by Student's t test; *P < 0.05, ***P < 0.005. n.s., not significant. under conditions of increased systemic insulin demand. Moreover, our finding that T2DM-associated TALK-1 A277E channels exacerbated Ca
2+
ER leak and ER stress responses suggests that defects in TALK-1 channel activity could contribute to islet ER dysfunction in diabetes. TALK-1 transcript abundance is reduced under conditions that cause ER stress in diabetes [such as palmitate or inflammatory cytokine treatment (79) ], which may be a protective mechanism to preserve b cell Ca 2+ ER homeostasis by reducing Ca 2+ ER leak. It will be important to determine how TALK-1 participates in the cellular response to other diabetes-associated ER stressors.
Mutations in other K2P channels have also been associated with various disorders that may be associated with defects in Ca 2+ ER handling. For example, dominant-negative mutations in TASK-1 or TASK-3 result in PAH or Birk-Barel syndrome, respectively (47) . We found that a PAH-linked mutation in TASK-1 (G203D) enhanced Ca 2+ ER stores relative to wild-type TASK-1. Thus, in patients with the TASK-1 G203D mutation, disruptions in ER/SR Ca 2+ handling may contribute to PAH (80) . In pulmonary arterial smooth muscle cells, impaired Ca 2+ ER transfer to mitochondria leads to pulmonary vascular remodeling, a defect that can be targeted with clinically used chemical chaperones to ameliorate PAH (80, 81) . Inhibition of TASK-1 using the specific inhibitor A293 causes pulmonary vascular remodeling and PAH in rats, and pharmacological activation of TASK-1 protects from the development of PAH (82) . TASK-3 also controls Ca 2+ ER , and a mutation in KCNK9 (which encodes TASK-3, G236R) causes Birk-Barel syndrome, which is characterized by intellectual disability, hypotonia, and facial dysmorphism. TASK-3 is also implicated in mitochondrial function (83), highlighting the importance of determining the relationship between TASK-3 modulation of Ca 2+ ER handling and mitochondrial function. Because we found that pharmacological regulation of TASK-1 could control primary cell Ca 2+ ER ,K2P channels (such as TASK-1, TASK-3, or TALK-1) could be targeted for cell-selective therapies to reduce ER dysfunction.
Not all K2P channels regulate Ca 2+ ER , as demonstrated by our finding that neither TREK-1 channels nor TREK-2 channels affected Ca 2+ ER homeostasis. These findings could be due to localization of these channels; TREK-1 channels are found primarily on the plasma membrane (84) , whereas the subcellular localization of TREK-2 channels has not been determined. However, all K + channels are assembled in the ER before their delivery to the plasma membrane (85) . It remains to be determined how certain K2P channels (specifically, TALK-1, TASK-1, and TASK-3) regulate Ca 2+ ER , whereas others (specifically, TREK-1 and TREK-2) do not. Because many K + channels, such as K ATP , require a physical interaction with the plasma membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ) to conduct K + , K2P channels that are dependent on PIP 2 for activity may not function in the ER membrane. This property could be due to intrinsically low PIP 2 concentrations on the ER membrane, which limits K + channel activity until they are transported to the plasma membrane (86) . TREK-1 is highly sensitive to PIP 2 , whereas both TASK-1 and TASK-3 channels, both of which affect Ca 2+ ER , are insensitive to PIP 2 (87) . Future studies are needed to better understand the regulatory mechanisms underlying K2P channel activity in the ER and how these affect Ca 2+ ER homeostasis.
In conclusion, we demonstrate that TALK-1 in the ER regulates Ca 2+ ER handling, thus controlling K slow activity, Ca 2+ influx, and insulin secretion. These findings highlight a physiological function of K2P channels in the regulation of Ca Fold increase in luminescence ER concentrations in 11 mM glucose (n = 4 independent experiments). Statistical significance was determined by Student's t test; *P < 0.05, **P < 0.01.
MATERIALS AND METHODS
Chemicals
Unless otherwise specified, all reagents were obtained from Sigma-Aldrich.
Mouse models
The mice used in this study were 8-to 12-week-old males on a C57Bl6/J background. The generation of Kcnk16 −/− (TALK-1 KO) mice has been previously described (28) . For experiments using mouse a cells, transgenic mice expressing tandem-dimer red fluorescent protein specifically in a cells were used (46) . All mice used in this study were handled in compliance with protocols reviewed and approved by the Vanderbilt University Institutional Animal Care and Use Committee, according to guidelines set forth by the National Institutes of Health.
Islet isolation and culture
Mouse islets were isolated using collagenase P (Roche) digestion of the pancreas and density gradient centrifugation (5) . Human islets from adult nondiabetic donors (donor information is provided in table S1) were obtained through isolation centers organized by the Integrated Islet Distribution Program. In experiments using D4ER, cells were transduced with Ad-D4ER (38) 48 hours before imaging. In human b cell experiments, cells were transfected with TALK-1 DN-or mCherry-expressing plasmids (28) . Islets and dispersed cells were cultured for 24 to 48 hours before experimentation (28) .
Cell culture and luciferase assays
The development of T-REx-293 cells with inducible expression of K2P channels has been previously described (43) . To measure TALK-1 and TASK-1 expression in induced cells, we ran lysates from TALK-1-or TASK-1-T-REx-293 cells treated for 24 hours with or without tetracycline (1 mg/ml) induction on 4 to 12% bis-tris polyacrylamide gels (Invitrogen). The protein was then transferred to a nitrocellulose blotting membrane (Bio-Rad), which was probed with TALK-1 (#NBP1-83071, Novus Biologicals) or TASK-1 (#49433, Abcam) antibodies. Equal loading of wells was assessed by stripping and reprobing membranes with a b-actin antibody (#4970, Cell Signaling Technologies). Representative blots are shown in fig. S4 . For experiments comparing the effects of wild-type TALK-1 and TALK-1 DN on Ca 2+ ER handling, HEK293 cells were transfected with pcDNA3.1 plasmids encoding these channels using Lipofectamine 3000 (Thermo Fisher Scientific) according to the manufacturer's instructions and imaged 48 hours after transfection. INS-1 (832/13) cells were cultured in RPMI 1640 supplemented with 15% fetal bovine serum and penicillin-streptomycin. INS-1 cells were transfected with p5xATF6-GL3 (#11976, Addgene) and plasmids encoding wild-type TALK-1, TALK-1 A277E, or TALK-1 DN (28). Cells were incubated overnight with vehicle (DMSO) or tunicamycin (0.25 mg/ml) for 16 to 20 hours before performing a luciferase assay using the Steady-Glo Luciferase Assay System (Promega) according to the manufacturer's instructions.
Patch clamp electrophysiology
An Axopatch 200B amplifier (Molecular Devices) was used to measure whole-cell K + channel currents in the voltage-clamp mode; currents were digitized using a Digidata 1440, low-pass-filtered at 1 kHz and sampled at 10 kHz. For K slow recordings, pipettes were filled with an intracellular solution (57) ). Nuclear patch clamp experiments were performed using the approach described by Mak and colleagues (50) . Nuclei were patched in a solution containing 150 mM KCl, 10 mM Hepes, 0.5 mM EGTA, and 0.36 mM CaCl 2 (pH 7.3 with KOH). Patch electrodes were pulled to a resistance of 8 to 10 megaohms, loaded with recording solution, and coated with Sigmacote. Single-channel currents were low-pass-filtered at 1 kHz and sampled at 50 kHz. When intracellular [Ca 2+ ] was clamped, cells were recorded using the whole-cell configuration using electrodes filled with a solution containing 140 mM KCl, 5 mM Hepes, 4 mM Mg·ATP, 1 mM EGTA, and 137 mM (for 50 2+ sensitivity of TALK-1 in b cells, the extracellular buffer was supplemented with a cocktail of K + channel inhibitors including 200 mM tolbutamide (MP Biomedicals), 10 mM tetraethylammonium chloride (Acros Organics), 100 nM apamin (Alomone Labs), 100 nM iberiotoxin (Alomone Labs), 100 nM TRAM-34 (Alomone Labs), and 10 mM nifedipine to inhibit VDCCs. Cells were recorded with a voltageclamp protocol used to assess K2P channel currents (28) . Recordings were analyzed using Clampfit 10 (Molecular Devices) and Microsoft Excel software.
Calcium imaging
Mouse and human b cells were loaded with 2 mM Fura-2 AM (Molecular Probes) and imaged as previously described (88) . CPA (Alomone Labs) was used at a concentration of 50 mM; ionomycin was used at a concentration of 5 mM (Alomone Labs). Human b cells were poststained for insulin (88) . In all experiments, cells were perfused with a flow of 2 ml min −1 at 37°C. For analysis of mouse b cell Ca 2+ ER uptake and release (51), Fura-2-loaded cells were incubated for 10 min in KRB supplemented with 11 mM glucose, 125 mM diazoxide (Enzo), and 1.25 mM thapsigargin (Alomone Labs) or vehicle. In high-[K + ] stimulus buffer, NaCl was reduced accordingly to maintain osmolarity. For experiments using D4ER, cells were incubated for 20 min in KRB containing 2 mM glucose before imaging.
For assays comparing the effects of expression of K2P channels in stably transduced T-REx-293 cells, 30,000 cells per well were seeded to 384-well black-wall, clear-bottom, amine-coated plates (BD Biosciences). Channel expression was induced with tetracycline (1 mg ml −1 ) in culture medium, and the cells were cultured overnight in a 5% CO 2 incubator at 37°C. The cells were washed using an ELx405CW plate washer (Bio-Tek Instruments Inc.) and loaded with 4 mM Fluo-4 AM (Molecular Probes) for 45 min in a 5% CO 2 incubator at 37°C. The cells were then washed with buffer supplemented with 1 mM EGTA and incubated in a 5% CO 2 incubator at 37°C for 8 min before imaging. Plates were then loaded into a whole-plate kinetic-imaging Functional Drug Screening System (FDSS 6000, Hamamatsu) and imaged at 37°C as previously described (43) .
When assessing the effects of TASK-1 or TASK-3 channel blockade, cells were loaded 3 hours before imaging with 500 nM ML365 (Tocris) or DMSO vehicle in culture medium, and in a cells, the culture medium also contained 125 mM diazoxide. ML365 was present throughout the experiment. For high-speed imaging of a cell Ca 2+ influx, cells were loaded with 5 mM Fluo-4 AM for 25 min, followed by washing with KRB (11 mM glucose). a Cells were then patched according to the perforated patch clamp protocol described above on a Nikon Eclipse TE2000-U microscope equipped with an X-Cite 120Q widefield fluorescence light source (Excelitas Technologies) and a D-104 microscope photometer (Photon Technologies Inc.). Upon obtaining a low-leak, gigaohm seal, the fluorescence light source was activated, and plasma membrane currents were recorded using the K slow voltage-clamp protocol (57) simultaneously with Fluo-4 fluorescence. Currents and photometer signal were digitized and sampled at 10 kHz. For analysis of the effects of TALK-1 on the CPA-induced Ca 2+ ER leak rate, T-REx-293 cells transfected with wild-type TALK-1 or TALK-1 DN and CEPIA1-ER (#58215, Addgene) (37) were permeabilized for 4 min in a 5% CO 2 incubator at 37°C in an intracellular buffer containing 140 mM potassium gluconate or 140 mM tris base (K + -free), 10 mM Hepes, 1 mM EGTA, 0.432 mM CaCl 2 , and 3 mM Mg·ATP, with sucrose added as needed to match osmolarity (pH 7.24), and supplemented with 50 mg ml −1 of digitonin (Santa Cruz Biotechnology). Cells were then washed for an additional 5 min in the appropriate buffer without digitonin before the start of imaging. To determine the rate constant of CPA-induced Ca 2+ leak, we fitted the normalized data to a one-phase exponential decay model using GraphPad Prism 7 software. Data were analyzed using Nikon Elements, Microsoft Excel, Clampfit 10, and GraphPad Prism 7 software.
Site-directed mutagenesis
The TASK-1 G203D point mutation was generated using a previously described approach (28) . The sequences of oligonucleotide primers (Integrated DNA Technologies) used to create the TASK-1 G203D mutant were 5′-ACCACCATCGGCTTCGACGACTACGTGGCGC-TGCAGA-3′ (forward) and 5′-TCTGCAGCGCCACGTAGTCGTC-GAAGCCGATGGTGGT-3′ (reverse). PCRs were performed in 50 ml using Q5 High-Fidelity DNA Polymerase (New England Biolabs) with 100 ng of pcDNA3.1-KCNK3 plasmid. DNA was then incubated with 1 ml of DpnI for 2 hours at 37°C. Clones were sequenced to confirm mutagenesis.
Real-time quantitative polymerase chain reaction qPCR of cDNA obtained from mouse islets was performed according to the approach described by Tong and colleagues (62) . A list of primers can be found in table S3.
Immunofluorescence
Processing and staining of paraffin-embedded mouse and human pancreas sections was performed as previously described (human donor information is provided in table S2) (28) . Sections were stained using primary antibodies against TALK-1 (1:175; #NBP1-83071, Novus Biologicals) and calreticulin (1:125; #N-19, Santa Cruz Biotechnology); secondary antibodies used were Alexa Fluor 488-conjugated donkey anti-rabbit (1:300; #711-546-152, Jackson ImmunoResearch) and DyLight 650-conjugated donkey anti-goat (1:250; #SA5-10089, Thermo Fisher Scientific). HEK293 cells cotransfected with TALK-1a or TALK-1b (28) and ER-targeted enhanced yellow fluorescent protein (#56589, Addgene) were washed twice with cold phosphate-buffered saline (PBS) and then fixed in 4% paraformaldehyde (Electron Microscopy Sciences) for 30 min at 4°C. Cells were then incubated in PBS supplemented with 0.2% bovine serum albumin (BSA), 2% normal donkey serum (NDS; Jackson ImmunoResearch), and 0.05% Triton X-100 for 1 hour, followed by incubation in PBS containing primary antibodies against TALK-1 (1:175) and green fluorescent protein (1:300; NB600-597, Novus Biologicals), 0.2% BSA, 1% NDS, and 0.1% Triton X-100, overnight at 4°C. After removal of the primary antibody solution, the cells were subjected to two 10-min PBS washes and then incubated in the dark for 1 hour at room temperature in PBS containing 1% NDS and secondary antibodies: Alexa Fluor 488-conjugated donkey antirabbit (1:300) and Alexa Fluor 647-conjugated goat anti-mouse (1:300; A21237, Thermo Fisher Scientific). The secondary antibody solution was removed, and the cells were subjected to three 8-min PBS washes before imaging. All images were obtained using a Zeiss LSM 710 or Zeiss LSM 780 confocal laser scanning microscope. Images were analyzed using ImageJ software.
For analysis of islet cell numbers, paraffin-embedded pancreata were processed as described above and stained using primary antibodies against insulin (1:500; #A0564, Dako), somatostatin (1:250; sc-7819, Santa Cruz Biotechnology), and glucagon (1:500; #15954-I-AP, Proteintech); secondary antibodies used were Alexa Fluor 488-conjugated donkey anti-rabbit (1:500; #711-546-152, Jackson ImmunoResearch), DyLight 650-conjugated donkey anti-goat (1:250; #SA5-10089, Thermo Fisher Scientific), and Cy3-conjugated donkey anti-guinea pig (1:500; #706-165-148, Jackson ImmunoResearch).
For analysis of HFD-induced islet-cell proliferation, age-matched wild-type and TALK-1 KO mice were placed on a HFD (60% kcal per fat; #D12492, Research Diets) for 10 days. Four days before sacrifice, mice were provided with drinking water containing BrdU (0.8 mg ml ). Paraffinembedded pancreata were processed as described above and were subjected to antigen retrieval performed in 1× NaCitrate (pH 6.0), for 14 min in a microwave at high power, followed by cooling at room temperature in 1× NaCitrate solution for 25 min. After antigen retrieval, slides were washed for 10 min in double-distilled H 2 O (ddH 2 O), followed by two 2-min washes in PBS. Sections were the stained using primary antibodies against insulin (1:500; #A0564, Dako), somatostatin (1:250; sc-7819, Santa Cruz Biotechnology), glucagon (1:500; #15954-I-AP, Proteintech), and BrdU (1:50; #G3G4, Developmental Studies Hybridoma Bank). Secondary antibodies used were Alexa Flour 647-conjugated goat anti-mouse (1:250; #A21237, Life Technologies), DyLight 488-conjugated donkey anti-mouse (1:300; #SA5-10166, Thermo Fishers Scientific), and Alexa Flour 594-conjugated donkey anti-guinea pig (1:400; #706-586-148, Jackson ImmunoResearch), DyLight 650-conjugated donkey anti-goat (1:250; #SA5-10089, Thermo Fisher Scientific), and Alexa Fluor 488-conjugated donkey anti-rabbit (1:500; #711-546-152, Jackson ImmunoResearch). Blocking was performed in a dark humidity chamber for 1 hour using Dako blocking solution (reference no. X0909). Primary antibodies were diluted to above concentrations in Dako antibody diluent solution (reference no. S3002) and incubated on the sections overnight at 4°C. After primary antibody incubation, slides were washed for 5 min in PBS twice. Secondary antibodies were diluted to the above concentrations in PBS supplemented with 5% NDS and incubated on slides in the dark for 2 hours at room temperature. Sections were then washed twice for 5 min in PBS, and 4′,6-diamidino-2-phenylindole (DAPI) was added (1:1000 for 2 min). After DAPI staining, sections were washed for 5 min in ddH 2 O and then mounted with a coverslip.
All sections were imaged with an Aperio ImageScope and analyzed using an algorithm developed with CytoNuclear FLv1.2 software (Aperio/Indica Labs). The algorithm is designed to take into account factors, such as nuclear staining, cytoplasm radius, nucelar size, nuclear roundness, and dye fluorescence wavelength (Cy2, Cy3, or Cy5), to identify, differentiate, and count b, d, and a cells. The algorithm was also used to count the number of b, d, and a cells on the slides labeled with BrdU, which was further analyzed using ImageJ software and Microsoft Excel.
Statistics
The data were presented as recordings that are averaged or representative of results obtained from at least three independent cultures. All values presented are means ± SEM. Statistical differences between means were assessed using Student's t test or one-way ANOVA, as appropriate. The significance of all experimental findings presented as fold changes was assessed by performing statistical tests on logtransformed data. P < 0.05 was considered as significant.
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